Paracrinology of islets and the paracrinopathy of diabetes
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
New results have brought to light the importance of the regulation of glucagon by β-cells in the development of diabetes. In this perspective, we examine the normal paracrinology of α- and β-cells in nondiabetic pancreatic islets. We propose a Sherringtonian model of coordinated reciprocal secretory responses of these juxtaposed cells that secrete glucagon and insulin, hormones with opposing actions on the liver. As insulin is a powerful inhibitor of glucagon, we propose that within-islet inhibition of α-cells by β-cells creates an insulin-to-glucagon ratio that maintains glycemic stability even in extremes of glucose influx or efflux. By contrast, in type 1 diabetes mellitus, α-cells lack constant action of high insulin levels from juxtaposed β-cells. Replacement with exogenous insulin does not approach paracrine levels of secreted insulin except with high doses that “overinsulinize” the peripheral insulin targets, thereby promoting glycemic volatility. Based on the stable normoglycemia of mice with type 1 diabetes during suppression of glucagon with leptin, we conclude that, in the absence of paracrine regulation of α-cells, tonic inhibition of α-cells improves the dysregulated glucose homeostasis. These results have considerable medical implications, as they suggest new approaches to normalize the extreme volatility of glycemia in diabetic patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The unique cytoarchitecture of human pancreatic islets has implications for islet cell function
Cabrera, O., Berman, D. M., Kenyon, N. S., Ricordi, C., Berggren, P.-O., & Caicedo, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510790103 · Cited by 1,312
Studies of pancreatic alpha cell function in normal and diabetic subjects
Unger, R. H., Aguilar-Parada, E., Müller, W. A., & Eisentraut, A. M. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106297 · Cited by 837
Self-citationAbnormal Alpha-Cell Function in Diabetes: Response to Carbohydrate and Protein Ingestion
Müller, W. A., Faloona, G. R., Aguilar-Parada, E., & Unger, R. H. (1970) · New England Journal of Medicine · doi:10.1056/nejm197007162830301 · Cited by 626
Self-citationNew Perspectives on the Microvasculature of the Islets of Langerhans in the Rat
Bonner-Weir, S., & Orci, L. (1982) · Diabetes · doi:10.2337/diab.31.10.883 · Cited by 499
Self-citationUnique Arrangement of α- and β-Cells in Human Islets of Langerhans
Bosco, D., Armanet, M., Morel, P., Niclauss, N., Sgroi, A., Muller, Y. D., Giovannoni, L., Parnaud, G., & Berney, T. (2010) · Diabetes · doi:10.2337/db09-1177 · Cited by 450
Hovorka, R., Allen, J. M., Elleri, D., Chassin, L. J., Harris, J., Xing, D., Kollman, C., Hovorka, T., Larsen, A. M. F., Nodale, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61998-x · Cited by 450
Gerich, J. E., Lorenzi, M., Bier, D. M., Schneider, V., Tsalikian, E., Karam, J. H., & Forsham, P. H. (1975) · New England Journal of Medicine · doi:10.1056/nejm197505082921901 · Cited by 354
Leptin therapy in insulin-deficient type I diabetes
Wang, M.-Y., Chen, L., Clark, G. O., Lee, Y., Stevens, R. D., Ilkayeva, O. R., Wenner, B. R., Bain, J. R., Charron, M. J., Newgard, C. B., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909422107 · Cited by 327
Self-citationType 1 diabetes and coronary artery disease
Orchard, T. J., Costacou, T., Kretowski, A., & Nesto, R. W. (2006) · Diabetes Care · doi:10.2337/dc06-1161 · Cited by 305
Macro- and Micro-Domains in the Endocrine Pancreas
Orci, L. (1982) · Diabetes · doi:10.2337/diab.31.6.538 · Cited by 305
Self-citationInsulin within islets is a physiologic glucagon release inhibitor
Maruyama, H., Hisatomi, A., Orci, L., Grodsky, G. M., & Unger, R. H. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111658 · Cited by 303 · cited 1×
“The physiologic importance of this intraislet vascular connection between βand α-cells is demonstrated by the fact that a neutralizing antiinsulin serum perfused into the artery of an isolated rat pancreas causes glucagon levels in the pancreatic venous effluent to soar precipitously, whereas nonimmune serum has no ef…”
BackgroundSelf-citationGlucagon and the a Cell: Physiology and Pathophysiology(First of Two Parts)
Unger, R. H., & Orci, L. (1981) · New England Journal of Medicine · doi:10.1056/nejm198106183042504 · Cited by 299
Self-citationAntidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Hedbacker, K., Birsoy, K., Wysocki, R. W., Asilmaz, E., Ahima, R. S., Farooqi, I. S., & Friedman, J. M. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2009.11.007 · Cited by 280 · cited 1×
“Glucagon Suppression in the Management of the Paracrinopathy of T1DM Recent studies have demonstrated remarkable antidiabetic properties of leptin, a powerful suppressor of glucagon (18, 19, 26).”
BackgroundGerich, J. E. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s117 · Cited by 264
The effect of experimental insulin deficiency on glucagon secretion
Müller, W. A., Faloona, G. R., & Unger, R. H. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106691 · Cited by 240
Self-citationEndocrine Pancreas: Three-Dimensional Reconstruction Shows Two Types of Islets of Langerhans
Baetens, D., Malaisse-Lagae, F., Perrelet, A., & Orci, L. (1979) · Science · doi:10.1126/science.390711 · Cited by 237
Self-citationGlucagon: Role in the Hyperglycemia of Diabetes Mellitus
Dobbs, R., Sakurai, H., Sasaki, H., Faloona, G., Valverde, I., Baetens, D., Orci, L., & Unger, R. (1975) · Science · doi:10.1126/science.1089999 · Cited by 229
Self-citationThe Hormonal Control of Hepatic Gluconeogenesis
EXTON, J. H., MALLETTE, L. E., JEFFERSON, L. S., WONG, E. H. A., FRIEDMANN, N., MILLER, T. B., & PARK, C. R. (1970) · Proceedings of the 1969 Laurentian Hormone Conference · doi:10.1016/b978-0-12-571126-5.50014-5 · Cited by 222
Making insulin-deficient type 1 diabetic rodents thrive without insulin
Yu, X., Park, B.-H., Wang, M.-Y., Wang, Z. V., & Unger, R. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806993105 · Cited by 219
Self-citationHyperglucagonemia and Its Suppression: Importance in the Metabolic Control of Diabetes
Raskin, P., & Unger, R. H. (1978) · New England Journal of Medicine · doi:10.1056/nejm197808312990901 · Cited by 196
Self-citation2 Intra-islet insulin—glucagon—somatostatin relationships
Samols, E., Bonner‐Weir, S., & Weir, G. C. (1986) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(86)80041-x · Cited by 173
Glucose Suppression of Glucagon Secretion
Le Marchand, S. J., & Piston, D. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.069195 · Cited by 156
Is HbA1c Affected by Glycemic Instability?
Derr, R., Garrett, E., Stacy, G. A., & Saudek, C. D. (2003) · Diabetes Care · doi:10.2337/diacare.26.10.2728 · Cited by 152
Shulman, G. I. (2004) · Physiology · doi:10.1152/physiol.00007.2004 · Cited by 149
Larsen, J. R., Brekke, M., Sandvik, L., Arnesen, H., Hanssen, K. F., & Dahl‐Jørgensen, K. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2637 · Cited by 136
The Effect of Insulin on the Alpha-Cell Response to Hyperglycemia in Long-Standing Alloxan Diabetes
Braaten, J. T., Faloona, G. R., & Unger, R. H. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107638 · Cited by 94
Self-citationThe Roles of Insulin, Glucagon, and Free Fatty Acids in the Regulation of Ketogenesis in Dogs
Keller, U., Chiasson, J.-L., Liljenquist, J. E., Cherrington, A. D., Jennings, A. S., & Crofford, O. B. (1977) · Diabetes · doi:10.2337/diab.26.11.1040 · Cited by 83
Islets in type 2 diabetes: in honor of Dr. Robert C. Turner
Bonner-Weir, S., & O'Brien, T. D. (2008) · Diabetes · doi:10.2337/db07-1842 · Cited by 66
Wilinska, M. E., Budiman, E. S., Taub, M. B., Elleri, D., Allen, J. M., Acerin, C. L. I., Dunger, D. B., & Hovorka, R. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300514 · Cited by 65
Rivera, N., Grueter, C. A., Edgerton, D. S., Rodewald, T., Neal, D. W., Nishimura, E., Larsen, M. O., Jacobsen, L. O., Kristensen, K., Brand, C. L., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.115717 · Cited by 43
Control of hepatic glucose output by glucagon and insulin in the intact dog.
Cherrington, A. D., Chiasson, J. L., LILJENQUIST, J. E., LACY, W. W., & Park, C. R. (1978) · PubMed · Cited by 36
Tominaga, M., Maruyama, H., Vasko, M. R., Baetens, D., Orci, L., & Unger, R. H. (1987) · Diabetes · doi:10.2337/diab.36.3.365 · Cited by 16
Self-citationPathophysiology of Insulin Secretion in Diabetes Mellitus
Ward, W. K., Beard, J. C., Halter, J. B., & Porte, D. (1985) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-1850-8_9 · Cited by 13
Cited by
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Glucagonocentric restructuring of diabetes: A pathophysiologic and therapeutic makeover
Unger, R. H., & Cherrington, A. D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60016 · Cited by 670
Self-citationPI3K/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis
Schultze, S. M., Hemmings, B. A., Niessen, M., & Tschopp, O. (2012) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411002109 · Cited by 540
Formation of a human β-cell population within pancreatic islets is set early in life
Gregg, B. E., Moore, P. C., Demozay, D., Hall, B. A., Li, M., Husain, A., Wright, A. J., Atkinson, M. A., & Rhodes, C. J. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1206 · Cited by 344
Leptin's Role in Lipodystrophic and Nonlipodystrophic Insulin-Resistant and Diabetic Individuals
Moon, H.-S., Dalamaga, M., Kim, S.-Y., Polyzos, S. A., Hamnvik, O.-P., Magkos, F., Paruthi, J., & Mantzoros, C. S. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1053 · Cited by 258
Metadata
- Authors
- Unger, R. H., & Orci, L.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2010-08-26
- Volume
- 107
- Issue
- 37
- Pages
- 16009-16012
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2110468437
- Cited by
- 269
- References
- 33
- FWCI
- 16.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.